Abstract
The kidney proximal tubule reabsorbs and degrades filtered plasma proteins to reclaim valuable nutrients and maintain body homeostasis. Defects in this process result in proteinuria, one of the most frequently used biomarkers of kidney disease. Filtered proteins enter proximal tubules via receptor-mediated endocytosis and are processed within a highly developed apical endo-lysosomal system (ELS). Proteinuria is a strong risk factor for chronic kidney disease progression and genetic disorders of the ELS cause hereditary kidney diseases, so deepening understanding of how the proximal tubule handles proteins is crucial for translational nephrology. Moreover, the ELS is both an entry point for nephrotoxins that induce tubular damage and a target for novel therapies to prevent it. Cutting-edge research techniques, such as functional intravital imaging and computational modelling, are shedding light on spatial and integrative aspects of renal tubular protein processing in vivo, how these are altered under pathological conditions and the consequences for other tubular functions. These insights have potentially important implications for understanding the origins of systemic complications arising in proteinuric states, and might lead to the development of new ways of monitoring and treating kidney diseases.
Key points
-
Uptake and degradation of filtered plasma proteins by kidney proximal tubules (PTs) is an important process in kidney physiology and body homeostasis. Defects in protein reabsorption lead to proteinuria, one of the most widely used disease biomarkers in nephrology.
-
PT cells are highly adapted to protein uptake and processing. These cells express large, multi-ligand receptors that bind a wide range of proteins and facilitate their internalization, and have a sophisticated apical endo-lysosomal system (ELS) that rapidly sorts and metabolizes proteins.
-
Protein uptake occurs mainly in the early PT, whereas small peptides are reclaimed in later regions, which shapes the axial topography of the PT. Some studies suggest that early PT cells release endocytic material, which can then be reabsorbed downstream, suggesting that tubular protein metabolism is an integrated process.
-
In response to increased glomerular protein filtration, PTs ramp up endocytic activity and uptake extends to the later regions to limit urinary protein loss. However, this axial remodelling might result in loss of other tubular functions, and dramatic increases in protein filtration can overwhelm and damage PTs, which is likely to be an important pathogenic mechanism in proteinuric kidney diseases.
-
Genetic defects in the PT ELS cause proteinuria and progressive loss of kidney function. Elucidation of underlying disease pathways is helping to identify potential molecular targets for therapeutic intervention.
-
The ELS provides protein nephrotoxins with an entry point into PT cells; temporary blockade of endocytosis might lower toxin uptake and reduce tubular damage. Moreover, conjugating compounds to proteins or peptides provides a mechanism for targeting PTs in vivo in drug development.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Maack, T., Johnson, V., Kau, S. T., Figueiredo, J. & Sigulem, D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int. 16, 251–270 (1979).
Inker, L. A. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N. Engl. J. Med. 385, 1737–1749 (2021).
Yu, Z. et al. Polygenic risk scores for kidney function and their associations with circulating proteome, and incident kidney diseases. J. Am. Soc. Nephrol. 32, 3161–3173 (2021).
Eshbach, M. L. & Weisz, O. A. Receptor-mediated endocytosis in the proximal tubule. Annu. Rev. Physiol. 79, 425–448 (2017).
Nielsen, R., Christensen, E. I. & Birn, H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 89, 58–67 (2016).
Jang, C. et al. Metabolite exchange between mammalian organs quantified in pigs. Cell Metab. 30, 594–606.e3 (2019).
Nykjaer, A. et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507–515 (1999).
Charnas, L. R., Bernardini, I., Rader, D., Hoeg, J. M. & Gahl, W. A. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N. Engl. J. Med. 324, 1318–1325 (1991).
Norden, A. G. W. et al. Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int. 57, 240–249 (2000).
Weisz, O. A. Endocytic adaptation to functional demand by the kidney proximal tubule. J. Physiol. 599, 3437–3446 (2021).
Goto, S., Hosojima, M., Kabasawa, H. & Saito, A. The endocytosis receptor megalin: from bench to bedside. Int. J. Biochem. Cell Biol. 157, 106393 (2023).
Christensen, E. I., Birn, H., Storm, T., Weyer, K. & Nielsen, R. Endocytic receptors in the renal proximal tubule. Physiology 27, 223–236 (2012).
Beenken, A. et al. Structures of LRP2 reveal a molecular machine for endocytosis. Cell 186, 821–836.e13 (2023).
Hurtado-Lorenzo, A. et al. V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol. 8, 124–136 (2006).
Christensen, E. I., Wagner, C. A. & Kaissling, B. Uriniferous tubule: structural and functional organization. Compr. Physiol. 2, 805–861 (2012).
Nagai, J. et al. Mutually dependent localization of megalin and Dab2 in the renal proximal tubule. Am. J. Physiol. Renal Physiol. 289, 569–576 (2005).
Shipman, K. E. & Weisz, O. A. Making a dent in Dent disease. Function 1, zqaa017 (2020).
Hatae, T., Ichimura, T., Ishida, T. & Sakurai, T. Apical tubular network in the rat kidney proximal tubule cells studied by thick-section and scanning electron microscopy. Cell Tissue Res. 288, 317–325 (1997).
Polesel, M. et al. Spatiotemporal organisation of protein processing in the kidney. Nat. Commun. 13, 1–13 (2022).
Huotari, J. & Helenius, A. Endosome maturation. EMBO J. 30, 3481–3500 (2011).
Yokota, S., Tsuji, H. & Kato, K. Immunocytochemical localization of cathepsin H in rat kidney. Light and electron microscopic study. Histochemistry 85, 223–230 (1986).
De Matteis, M. A., Staiano, L., Emma, F. & Devuyst, O. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat. Rev. Nephrol. 13, 455–470 (2017).
Schuh, C. D. et al. Combined structural and functional imaging of the kidney reveals major axial differences in proximal tubule endocytosis. J. Am. Soc. Nephrol. 29, 2696–2712 (2018).
Christensen, E. I. A well-developed endolysosomal system reflects protein reabsorption in segment 1 and 2 of rat proximal tubules. Kidney Int. 99, 841–853 (2020).
Edwards, A., Long, K. R., Baty, C. J., Shipman, K. E. & Weisz, O. A. Modelling normal and nephrotic axial uptake of albumin and other filtered proteins along the proximal tubule. J. Physiol. 600, 1933–1952 (2022).
Caruso-Meves, C., Pinheiro, A. A. S., Cai, H., Souza-Menezes, J. & Guggino, W. B. PKB and megalin determine the survival or death of renal proximal tubule cells. Proc. Natl Acad. Sci. USA 103, 18810–18815 (2006).
Rbaibi, Y. et al. Megalin, cubilin, and Dab2 drive endocytic flux in kidney proximal tubule cells. Mol. Biol. Cell 34, ar74 (2023).
Christensen, E. I. Rapid protein uptake and digestion in proximal tubule lysosomes. Kidney Int. 10, 301–310 (1976).
Osicka, T. M., Houlihan, C. A., Chan, J. G., Jerums, G. & Comper, W. D. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 49, 1579–1584 (2000).
Gudehithlu, K. P., Pegoraro, A. A., Dunea, G., Arruda, J. A. L. & Singh, A. K. Degradation of albumin by the renal proximal tubule-cells and the subsequent fate of its fragments. Kidney Int. 65, 2113–2122 (2004).
Weyer, K., Nielsen, R., Christensen, E. I. & Birn, H. Generation of urinary albumin fragments does not require proximal tubular uptake. J. Am. Soc. Nephrol. 23, 591–596 (2012).
Grove, K. J. et al. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney. Kidney Int. 94, 292–302 (2018).
Chen, L., Chou, C.-L. & Knepper, M. A. A comprehensive map of mRNAs and their isoforms across all 14 renal tubule segments of mouse. J. Am. Soc. Nephrol. 32, 897–912 (2021).
Kugler, P. Localization of aminopeptidase A (angiotensinase A) in the rat and mouse kidney. Histochemistry 72, 269–278 (1981).
Jedrzejewski, K. & Kugler, P. Peptidases in the kidney and urine of rats after castration. Histochemistry 74, 63–84 (1982).
Kugler, P., Wolf, G. & Scherberich, J. Histochemical demonstration of peptidases in the human kidney. Histochemistry 83, 337–341 (1985).
Neiss, W. F. & Klehn, K. L. The postnatal development of the rat kidney, with special reference to the chemodifferentiation of the proximal tubule. Histochemistry 73, 251–268 (1981).
Daniel, H. & Rubio-Aliaga, I. An update on renal peptide transporters. Am. J. Physiol. Renal Physiol. 284, F885–F892 (2003).
Ansermet, C. et al. Renal tubular arginase-2 participates in the formation of the corticomedullary urea gradient and attenuates kidney damage in ischemia-reperfusion injury in mice. Acta Physiol. 229, e13457 (2020).
Gudehithlu, K. P. et al. Peptiduria: a potential early predictor of diabetic kidney disease. Clin. Exp. Nephrol. 23, 56–64 (2019).
Rudolphi, C. F., Blijdorp, C. J., Van Willigenburg, H., Salih, M. & Hoorn, E. J. Urinary extracellular vesicles and tubular transport. Nephrol. Dial. Transplant. 38, 1583–1590 (2023).
De, S. et al. Exocytosis-mediated urinary full-length megalin excretion is linked with the pathogenesis of diabetic nephropathy. Diabetes 66, 1391–1404 (2017).
Lisi, S. et al. Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release. Proc. Natl Acad. Sci. USA 100, 14858–14863 (2003).
Dickson, L. E., Wagner, M. C., Sandoval, R. M. & Molitoris, B. A. The proximal tubule and albuminuria: really! J. Am. Soc. Nephrol. 25, 443–453 (2014).
Tenten, V. et al. Albumin is recycled from the primary urine by tubular transcytosis. J. Am. Soc. Nephrol. 24, 1966–1980 (2013).
Molitoris, B. A., Sandoval, R. M., Yadav, S. P. S. & Wagner, M. C. Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications. Physiol. Rev. 102, 1625–1667 (2022).
Birn, H., Nielsen, R. & Weyer, K. Tubular albumin uptake: is there evidence for a quantitatively important, receptor-independent mechanism? Kidney Int. 104, 1069–1073 (2023).
Molitoris, B. A., Dunn, K. W. & Sandoval, R. M. Proximal tubule role in albumin homeostasis: controversy, species differences, and the contributions of intravital microscopy. Kidney Int. 104, 1065–1069 (2023).
Peti-Peterdi, J. Independent two-photon measurements of albumin GSC give low values. Am. J. Physiol. Renal Physiol. 296, F1255-F1257 (2009).
Tojo, A. & Endou, H. Intrarenal handling of proteins in rats using fractional micropuncture technique. Am. J. Physiol. 263, F601–F606 (1992).
Weyer, K. et al. Abolishment of proximal tubule albumin endocytosis does not affect plasma albumin during nephrotic syndrome in mice. Kidney Int. 93, 335–342 (2018).
Martins, J. R. et al. Intravital kidney microscopy: entering a new era. Kidney Int. 100, 527–535 (2021).
Bedin, M. et al. Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function. J. Clin. Invest. 130, 335–344 (2020).
Cravedi, P. & Remuzzi, G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br. J. Clin. Pharmacol. 76, 516–523 (2013).
Zoja, C., Abbate, M. & Remuzzi, G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol. Dial. Transplant. 30, 706–712 (2015).
Liu, W. J. et al. Urinary proteins induce lysosomal membrane permeabilization and lysosomal dysfunction in renal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 308, F639–F649 (2015).
Cybulsky, A. V. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat. Rev. Nephrol. 13, 681–696 (2017).
Long, K. R., Rbaibi, Y., Gliozzi, M. L., Ren, Q. & Weisz, O. A. Differential kidney proximal tubule cell responses to protein overload by albumin and its ligands. Am. J. Physiol. Renal Physiol. 318, F851–F859 (2020).
Meyrier, A. & Niaudet, P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 94, 861–869 (2018).
Guo, J. K. et al. Increased tubular proliferation as an adaptive response to glomerular albuminuria. J. Am. Soc. Nephrol. 23, 429–437 (2012).
Dizin, E. et al. Time-course of sodium transport along the nephron in nephrotic syndrome: the role of potassium. FASEB J. 34, 2408–2424 (2020).
De Seigneux, S. et al. Proteinuria increases plasma phosphate by altering its tubular handling. J. Am. Soc. Nephrol. 26, 1608–1618 (2015).
Schaeverbeke, J. & Cheignon, M. Differentiation of glomerular filter and tubular reabsorption apparatus during foetal development of the rat kidney. J. Embryol. Exp. Morphol. 58, 157–175 (1980).
Abbate, M. et al. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J. Am. Soc. Nephrol. 19, 1158–1167 (2008).
Kaissling, B., LeHir, M. & Kriz, W. Renal epithelial injury and fibrosis. Biochim. Biophys. Acta 1832, 931–939 (2013).
Theilig, F. et al. Abrogation of protein uptake through megalin-deficient proximal tubules does not safeguard against tubulointerstitial injury. J. Am. Soc. Nephrol. 18, 1824–1834 (2007).
Faivre, A. et al. Spatiotemporal landscape of kidney tubular responses to glomerular proteinuria. J. Am. Soc. Nephrol. 35, 854–869 (2024).
Rutkowski, J. M. et al. Adiponectin promotes functional recovery after podocyte ablation. J. Am. Soc. Nephrol. 24, 268–282 (2013).
Sweet, D. H., Bush, K. T. & Nigam, S. K. The organic anion transporter family: from physiology to ontogeny and the clinic. Am. J. Physiol. Renal Physiol. 281, F197–F205 (2001).
Aggarwal, S. et al. SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys. Science 383, 1–14 (2024).
Lidberg, K. A. et al. Serum protein exposure activates a core regulatory program driving human proximal tubule injury. J. Am. Soc. Nephrol. 33, 949–965 (2022).
O’Neill, W. C. Serum protein-induced tubular injury. J. Am. Soc. Nephrol. 33, 1627 (2022).
Ying, W. Z. et al. Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury. J. Clin. Invest. 129, 2792–2806 (2019).
Kudose, S. et al. Clinicopathologic spectrum of lysozyme-associated nephropathy. Kidney Int. Rep. 8, 1585–1595 (2023).
Molitoris, B. A. & Wagner, M. C. Is albumin toxic to the kidney? It depends. Clin. J. Am. Soc. Nephrol. 18, 1222–1224 (2023).
Nielsen, R. et al. Increased lysosomal proteolysis counteracts protein accumulation in the proximal tubule during focal segmental glomerulosclerosis. Kidney Int. 84, 902–910 (2013).
Weisz, O. A. Considerations in comparing proximal tubule cell culture models. J. Am. Soc. Nephrol. 32, 2099–2100 (2021).
Peruchetti, D. B., Cheng, J., Caruso-Neves, C. & Guggino, W. B. Mis-regulation of mammalian target of rapamycin (mTOR) complexes induced by albuminuria in proximal tubules. J. Biol. Chem. 289, 16790–16801 (2014).
Long, K. R. et al. Cubilin-, megalin-, and Dab2-dependent transcription revealed by CRISPR/Cas9 knockout in kidney proximal tubule cells. Am. J. Physiol. Renal Physiol. 322, F14–F26 (2022).
Wang, T., Weinbaum, S. & Weinstein, A. M. Regulation of glomerulotubular balance: flow-activated proximal tubule function. Pflugers Arch. Eur. J. Physiol. 469, 643–654 (2017).
Gleixner, E. M. et al. V-ATPase/mTOR signaling regulates megalin-mediated apical endocytosis. Cell Rep. 8, 10–19 (2014).
Grahammer, F. et al. mTOR regulates endocytosis and nutrient transport in proximal tubular cells. J. Am. Soc. Nephrol. 28, 230–241 (2017).
Long, K. R. et al. Proximal tubule apical endocytosis is modulated by fluid shear stress via an mTOR-dependent pathway. Mol. Biol. Cell 28, 2508–2517 (2017).
Berquez, M. et al. Lysosomal cystine export regulates mTORC1 signaling to guide kidney epithelial cell fate specialization. Nat. Commun. 14, 1–21 (2023).
Silva-Aguiar, R. P. et al. Albumin expands albumin reabsorption capacity in proximal tubule epithelial cells through a positive feedback loop between AKT and megalin. Int. J. Mol. Sci. 23, 848 (2022).
Rinschen, M. M. et al. VPS34-dependent control of apical membrane function of proximal tubule cells and nutrient recovery by the kidney. Sci. Signal. 15, eabo7940 (2022).
Lynch, M. R. et al. TFEB-driven lysosomal biogenesis is pivotal for PGC1α-dependent renal stress resistance. JCI Insight 5, e126749 (2019).
Nakamura, S. et al. LC3 lipidation is essential for TFEB activation during the lysosomal damage response to kidney injury. Nat. Cell Biol. 22, 1252–1263 (2020).
Cui, Z. et al. Structure of the lysosomal mTORC1–TFEB–Rag–Ragulator megacomplex. Nature 614, 572–579 (2023).
Raghavan, V., Rbaibi, Y., Pastor-Soler, N. M., Carattino, M. D. & Weisz, O. A. Shear stress-dependent regulation of apical endocytosis in renal proximal tubule cells mediated by primary cilia. Proc. Natl Acad. Sci. USA 111, 8506–8511 (2014).
Thelen, S., Abouhamed, M., Ciarimboli, G., Edemir, B. & Bähler, M. Rho GAP myosin IXa is a regulator of kidney tubule function. Am. J. Physiol. Renal Physiol. 309, F501–F513 (2015).
Nielsen, R. et al. Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells. Proc. Natl Acad. Sci. USA 104, 5407–5412 (2007).
Desmond, M. J. et al. Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2. Am. J. Physiol. Renal Physiol. 300, 1437–1447 (2011).
Skeby, C. K. et al. Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome. Kidney Int. 104, 754–768 (2023).
Wong, K. et al. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort. Lancet 403, 1279–1289 (2024).
Keller, S. A. et al. Drug discovery and therapeutic perspectives for proximal tubulopathies. Kidney Int. 104, 1103–1112 (2023).
Issler, N. et al. A founder mutation in EHD1 presents with tubular proteinuria and deafness. J. Am. Soc. Nephrol. 33, 732–745 (2022).
van der Wijst, J., Belge, H., Bindels, R. J. M. & Devuyst, O. Learning physiology from inherited kidney disorders. Physiol. Rev. 99, 1575–1653 (2019).
Devuyst, O., Christie, P. T., Courtoy, P. J., Beauwens, R. & Thakker, R. V. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent’s disease. Hum. Mol. Genet. 8, 247–257 (1999).
Christensen, E. I. et al. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc. Natl Acad. Sci. USA 100, 8472–8477 (2003).
Hennings, J. C. et al. A mouse model for distal renal tubular acidosis reveals a previously unrecognized role of the V-ATPase a4 subunit in the proximal tubule. EMBO Mol. Med. 4, 1057–1071 (2012).
Gorvin, C. M. et al. Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients. Proc. Natl Acad. Sci. USA 110, 7014–7019 (2013).
Novarino, G., Weinert, S., Rickheit, G. & Jentsch, T. J. Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328, 1398–1401 (2010).
Shipman, K. E. et al. Impaired endosome maturation mediates tubular proteinuria in Dent disease cell culture and mouse models. J. Am. Soc. Nephrol. 34, 619-640 (2023).
Prange, J. A. et al. Overcoming endocytosis deficiency by cubosome nanocarriers. ACS Appl. Bio Mater. 2, 2490–2499 (2019).
Vicinanza, M. et al. OCRL controls trafficking through early endosomes via PtdIns4,5P 2-dependent regulation of endosomal actin. EMBO J. 30, 4970–4985 (2011).
Festa, B. P. et al. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease. Hum. Mol. Genet. 28, 1931–1946 (2019).
Berquez, M. et al. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease. Kidney Int. 98, 883–896 (2020).
Vilasi, A. et al. Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am. J. Physiol. Renal Physiol. 293, F456–F467 (2007).
Rega, L. R., De Leo, E., Nieri, D. & Luciani, A. Defective cystinosin, aberrant autophagy−endolysosome pathways, and storage disease: towards assembling the puzzle. Cell 11, 326 (2022).
Festa, B. P. et al. Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney. Nat. Commun. 9, 161 (2018).
de Leo, E. et al. Cell-based phenotypic drug screening identifies luteolin as candidate therapeutic for nephropathic cystinosis. J. Am. Soc. Nephrol. 31, 1522–1537 (2020).
Janssens, V. et al. Protection of cystinotic mice by kidney-specific megalin ablation supports an endocytosis-based mechanism for nephropathic cystinosis progression. J. Am. Soc. Nephrol. 30, 2177–2190 (2019).
Rega, L. R. et al. Dietary supplementation of cystinotic mice by lysine inhibits the megalin pathway and decreases kidney cystine content. Sci. Rep. 13, 1–14 (2023).
Ren, Q. et al. Shear stress and oxygen availability drive differential changes in opossum kidney proximal tubule cell metabolism and endocytosis. Traffic 20, 448–459 (2019).
Chen, Z. et al. Transgenic zebrafish modeling low-molecular-weight proteinuria and lysosomal storage diseases. Kidney Int. 97, 1150–1163 (2020).
Gaide Chevronnay, H. P. et al. Time course of pathogenic and adaptation mechanisms in cystinotic mouse kidneys. J. Am. Soc. Nephrol. 25, 1256–1269 (2014).
Gu, X. et al. Kidney disease genetic risk variants alter lysosomal beta-mannosidase (MANBA) expression and disease severity. Sci. Transl. Med. 13, eaaz1458 (2021).
Qiu, C. et al. Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease. Nat. Med. 24, 1721–1731 (2018).
Wu, M. et al. Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease. Cell Death Dis. 12, 1–10 (2021).
Kolli, R. T. et al. The urinary proteome infers dysregulation of mitochondrial, lysosomal, and protein reabsorption processes in chronic kidney disease of unknown etiology (CKDu). Am. J. Physiol. Renal Physiol. 324, F387–F403 (2023).
Vervaet, B. A. et al. Chronic interstitial nephritis in agricultural communities is a toxin-induced proximal tubular nephropathy. Kidney Int. 97, 350–369 (2020).
Bugarski, M., Ghazi, S., Polesel, M., Martins, J. R. & Hall, A. M. Changes in NAD and lipid metabolism drive acidosis-induced acute kidney injury. J. Am. Soc. Nephrol. 32, 342–356 (2021).
Bovée, D. M., Janssen, J. W., Zietse, R., Danser, A. H. J. & Hoorn, E. J. Acute acid load in chronic kidney disease increases plasma potassium, plasma aldosterone and urinary renin. Nephrol. Dial. Transplant. 35, 1821–1823 (2020).
Lee, L. E., Doke, T., Mukhi, D. & Susztak, K. The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int. 106, 24–34 (2024).
Wright, J. et al. Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney. Physiol. Genomics 33, 341–354 (2008).
Simons, M. The benefits of tubular proteinuria: an evolutionary perspective. J. Am. Soc. Nephrol. 29, 710–712 (2018).
Gros, F. & Muller, S. The role of lysosomes in metabolic and autoimmune diseases. Nat. Rev. Nephrol. 19, 366–383 (2023).
Matsushita, K. et al. Cilastatin ameliorates rhabdomyolysis-induced AKI in mice. J. Am. Soc. Nephrol. 32, 2579–2594 (2021).
Dickenmann, M., Oettl, T. & Mihatsch, M. J. Narrative review osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am. J. Kidney Dis. 51, 491–503 (2008).
Hori, Y. et al. Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J. Am. Soc. Nephrol. 28, 1783–1791 (2017).
Wagner, M. C. et al. Lrpap1 (RAP) inhibits proximal tubule clathrin mediated and clathrin independent endocytosis, ameliorating renal aminoglycoside nephrotoxicity. Kidney360 4, 591–605 (2023).
Rinschen, M. M. et al. Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension. Nat. Commun. 13, 1–17 (2022).
Parihar, A. S., Chopra, S. & Prasad, V. Nephrotoxicity after radionuclide therapies. Transl. Oncol. 15, 101295 (2022).
Trac, N. et al. Spotlight on genetic kidney diseases: a call for drug delivery and nanomedicine solutions. ACS Nano 17, 6165–6177 (2023).
Wang, J., Masehi-Lano, J. J. & Chung, E. J. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease. Biomater. Sci. 5, 1450–1459 (2017).
Peek, J. L. & Wilson, M. H. Cell and gene therapy for kidney disease. Nat. Rev. Nephrol. 19, 451–462 (2023).
Geo, H. N. et al. Renal nano-drug delivery for acute kidney injury: current status and future perspectives. J. Control. Release 343, 237–254 (2022).
Uchida, M. et al. The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration. J. Clin. Invest. 129, 3941–3951 (2019).
Acknowledgements
A.M.H. has received support from the Swiss National Centre for Competence in Research (NCCR) Kidney Control of Homeostasis and the Swiss National Science Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.M.H. has received consultancy fees from Proteinqure and AstraZeneca.
Peer review
Peer review information
Nature Reviews Nephrology thanks Celso Caruso-Neves and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hall, A.M. Protein handling in kidney tubules. Nat Rev Nephrol 21, 241–252 (2025). https://doi.org/10.1038/s41581-024-00914-1
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41581-024-00914-1